BioSpace News Archive

Pharm Country

PaxMedica Announces Closing of $7.0 Million Public Offering

PaxMedica, Inc. announced the closing of its previously announced public offering of an aggregate of 5,384,615 shares of its common stock and warrants to purchase up to 5,384,615 shares of common stock, at a public offering price of $1.30 per share and accompanying warrant.

November 22, 2023
·
4 min read
Drug Development

PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome

PharmAbcine Inc. announces the publication of preclinical research in Science Advances, highlighting the potential of its Tie2-activating antibody program, PMC-403, in treating Idiopathic Systemic Capillary Leak Syndrome.

November 22, 2023
·
4 min read
Drug Development

Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy

Entrada Therapeutics, Inc. today announced the completion of dosing for the first and second cohorts of its Phase 1 clinical trial, ENTR-601-44-101.

November 22, 2023
·
7 min read
Drug Development

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

Immutep Limited today announces that the INSIGHT-003 trial has been expanded to four sites across Germany including the University Clinic of Ruhr Universität Bochum and the Lung Clinic Cologne-Merheim.

November 22, 2023
·
3 min read
Pharm Country

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Insomnia or AnxietyGrant of Its Newest U.S. Patent Expands Anavex’s Compounds Intellectual Property Portfolio

Anavex Life Sciences Corp. today announced that the United States Patent and Trademark Office (USPTO) granted U.S. Patent No. 11,813,242 entitled “A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION”.

November 22, 2023
·
5 min read
FDA

Alladapt Immunotherapeutics Receives FDA Fast Track Designation for ADP101 for the Treatment of Mono- and Multi-Food Allergies

Alladapt Immunotherapeutics, today announced that ADP101, its investigational multi-food oral immunotherapy (mOIT) designed to simultaneously treat allergy to one or more of the world’s most significant food allergens, received Fast Track Designation from the U.S. Food and Drug Administration (FDA).

November 22, 2023
·
5 min read
BioMidwest

Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Celcuity Inc. today announced its participation in the 6th Annual Evercore ISI HealthCONx Conference held in Miami.

November 22, 2023
·
1 min read
Pharm Country

Viatris Partners With Comfort Cases to Support Youth in U.S. Foster Care

Viatris, a global healthcare company, announced that it has packed 1,000 backpacks in partnership with Comfort Cases, a nonprofit organization that provides comfort and personal care items for children entering the foster care system.

November 22, 2023
·
4 min read
Genetown

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

Sapphiros is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.

November 22, 2023
·
2 min read
Lone Star Bio

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy

CNS Pharmaceuticals, Inc. today announced the presentation of updated safety data from the ongoing potentially pivotal study evaluating Berubicin.

November 22, 2023
·
7 min read